Factory

Factory is a specialized biotechnology venture studio and company builder focused on translating breakthrough scientific discoveries into high-impact therapeutic companies. The firm operates by identifying novel biological insights and providing the necessary operational, strategic, and financial infrastructure to advance these concepts through the pre-clinical stage. By leveraging a centralized team of drug discovery experts and a network of academic collaborators, Factory aims to de-risk early-stage assets before spinning them out into independent entities. Their portfolio spans diverse therapeutic areas, including oncology and immunology, with a focus on innovative modalities such as cell and gene therapies. Factory's unique model streamlines the path from laboratory research to clinical development, ensuring that promising science reaches patients more efficiently.